Evidence map›Paper›PMID 31267318›Full record

ReviewWorld journal of microbiology & biotechnology2019

Discovery pipelines for marine resources: an ocean of opportunity for biotechnology?

D Smith, A G Buddie, R J M Goss, J Overmann, C Lepleux, M Brönstrup, B Kloareg, T Meiners, P Brennecke, A Ianora and 3 more

Abstract readReview
In one paragraph

Review in World journal of microbiology & biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Saturated Iso-Type Fatty Acids from the Marine BacteriumPharmaceuticals (Basel, Switzerland) · 2024
    Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

D SmithCAB International (CABI), Bakeham Lane, Egham, TW20 9TY, Surrey, UK. d.smith@cabi.org.ORCID http://orcid.org/0000-0003-1821-5141
A G BuddieCAB International (CABI), Bakeham Lane, Egham, TW20 9TY, Surrey, UK.ORCID http://orcid.org/0000-0002-7677-9300
R J M GossSchool of Chemistry, Biomedical Sciences Research Complex, University of St Andrews, Fife, KY169ST, UK.ORCID http://orcid.org/0000-0001-9869-8205
J OvermannLeibniz-Institut DSMZ-Deutsche Sammlung Von Mikroorganismen Und Zellkulturen GmbH, Inhoffenstraße 7 B, 38124, Braunschweig, Germany.ORCID http://orcid.org/0000-0003-3909-7201
C LepleuxLeibniz-Institut DSMZ-Deutsche Sammlung Von Mikroorganismen Und Zellkulturen GmbH, Inhoffenstraße 7 B, 38124, Braunschweig, Germany.ORCID http://orcid.org/0000-0003-3347-2090
M BrönstrupDepartment of Chemical Biology, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, 38124, Braunschweig, Germany.ORCID http://orcid.org/0000-0002-8971-7045
B KloaregStation Biologique, CS 90074, 29688, Roscoff CEDEX, France.
T MeinersLeibniz-Institute for Molecular Pharmacology, Robert-Roessle-Strasse 10, 13125, Berlin, Germany.ORCID http://orcid.org/0000-0002-6607-8463
P BrenneckeLeibniz-Institute for Molecular Pharmacology, Robert-Roessle-Strasse 10, 13125, Berlin, Germany.
A IanoraStazione Zoologica "A. Dohrn" Villa Comunale, 80121, Naples, Italy.ORCID http://orcid.org/0000-0002-6511-5517
F-Y BougetLaboratoire D'Océanographie Microbienne (LOMIC) - UMR 7621 CNRS-UPMC, Avenue Fontaulé, 66650, Banyuls sur mer, France.
P GribbonFraunhofer IME, ScreeningPort, Schnackenburgallee 114, 22525, Hamburg, Germany.ORCID http://orcid.org/0000-0001-7655-2459
M PinaCRBIP, Institut Pasteur, 25-28 rue du Dr. Roux, 75015, Paris, France.ORCID http://orcid.org/0000-0001-9427-662X

Funding

European Union 645884
6 · The paper itself

Abstract

Marine microbial diversity offers enormous potential for discovery of compounds of crucial importance in healthcare, food security and bioindustry. However, access to it has been hampered by the difficulty of accessing and growing the organisms for study. The discovery and exploitation of marine bioproducts for research and commercial development requires state-of-the-art technologies and innovative approaches. Technologies and approaches are advancing rapidly and keeping pace is expensive and time consuming. There is a pressing need for clear guidance that will allow researchers to operate in a way that enables the optimal return on their efforts whilst being fully compliant with the current regulatory framework. One major initiative launched to achieve this, has been the advent of European Research Infrastructures. Research Infrastructures (RI) and associated centres of excellence currently build harmonized multidisciplinary workflows that support academic and private sector users. The European Marine Biological Research Infrastructure Cluster (EMBRIC) has brought together six such RIs in a European project to promote the blue bio-economy. The overarching objective is to develop coherent chains of high-quality services for access to biological, analytical and data resources providing improvements in the throughput and efficiency of workflows for discovery of novel marine products. In order to test the efficiency of this prototype pipeline for discovery, 248 rarely-grown organisms were isolated and analysed, some extracts demonstrated interesting biochemical properties and are currently undergoing further analysis. EMBRIC has established an overarching and operational structure to facilitate the integration of the multidisciplinary value chains of services to access such resources whilst enabling critical mass to focus on problem resolution.

Indexed as

Biological ProductsBiotechnologyOceans and SeasAquatic OrganismsBacteriaBiodiversityDrug DiscoveryFungiMetabolomicsSeawaterBiological ProductsDiscovery pipelineMarinemicrobial domain Biological Resource Centres (mBRC)Microorganism

Identifiers

PMID31267318
PMCPMC6606657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.